A New Screening Method for the Directed Evolution of Thermostable Bacteriolytic Enzymes
Directed evolution is defined as a method to harness natural selection in order to engineer proteins to acquire particular properties that are not associated with the protein in nature. Literature has provided numerous examples regarding the implementation of directed evolution to successfully alter...
Saved in:
Published in | Journal of visualized experiments no. 69 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
United States
MyJove Corporation
07.11.2012
|
Subjects | |
Online Access | Get full text |
ISSN | 1940-087X 1940-087X |
DOI | 10.3791/4216 |
Cover
Loading…
Abstract | Directed evolution is defined as a method to harness natural selection in order to engineer proteins to acquire particular properties that are not associated with the protein in nature. Literature has provided numerous examples regarding the implementation of directed evolution to successfully alter molecular specificity and catalysis(1). The primary advantage of utilizing directed evolution instead of more rational-based approaches for molecular engineering relates to the volume and diversity of variants that can be screened(2). One possible application of directed evolution involves improving structural stability of bacteriolytic enzymes, such as endolysins. Bacteriophage encode and express endolysins to hydrolyze a critical covalent bond in the peptidoglycan (i.e. cell wall) of bacteria, resulting in host cell lysis and liberation of progeny virions. Notably, these enzymes possess the ability to extrinsically induce lysis to susceptible bacteria in the absence of phage and furthermore have been validated both in vitro and in vivo for their therapeutic potential(3-5). The subject of our directed evolution study involves the PlyC endolysin, which is composed of PlyCA and PlyCB subunits(6). When purified and added extrinsically, the PlyC holoenzyme lyses group A streptococci (GAS) as well as other streptococcal groups in a matter of seconds and furthermore has been validated in vivo against GAS(7). Significantly, monitoring residual enzyme kinetics after elevated temperature incubation provides distinct evidence that PlyC loses lytic activity abruptly at 45 °C, suggesting a short therapeutic shelf life, which may limit additional development of this enzyme. Further studies reveal the lack of thermal stability is only observed for the PlyCA subunit, whereas the PlyCB subunit is stable up to ~90 °C (unpublished observation). In addition to PlyC, there are several examples in literature that describe the thermolabile nature of endolysins. For example, the Staphylococcus aureus endolysin LysK and Streptococcus pneumoniae endolysins Cpl-1 and Pal lose activity spontaneously at 42 °C, 43.5 °C and 50.2 °C, respectively(8-10). According to the Arrhenius equation, which relates the rate of a chemical reaction to the temperature present in the particular system, an increase in thermostability will correlate with an increase in shelf life expectancy(11). Toward this end, directed evolution has been shown to be a useful tool for altering the thermal activity of various molecules in nature, but never has this particular technology been exploited successfully for the study of bacteriolytic enzymes. Likewise, successful accounts of progressing the structural stability of this particular class of antimicrobials altogether are nonexistent. In this video, we employ a novel methodology that uses an error-prone DNA polymerase followed by an optimized screening process using a 96 well microtiter plate format to identify mutations to the PlyCA subunit of the PlyC streptococcal endolysin that correlate to an increase in enzyme kinetic stability (Figure 1). Results after just one round of random mutagenesis suggest the methodology is generating PlyC variants that retain more than twice the residual activity when compared to wild-type (WT) PlyC after elevated temperature treatment. |
---|---|
AbstractList | Directed evolution is defined as a method to harness natural selection in order to engineer proteins to acquire particular properties that are not associated with the protein in nature. Literature has provided numerous examples regarding the implementation of directed evolution to successfully alter molecular specificity and catalysis1. The primary advantage of utilizing directed evolution instead of more rational-based approaches for molecular engineering relates to the volume and diversity of variants that can be screened2. One possible application of directed evolution involves improving structural stability of bacteriolytic enzymes, such as endolysins. Bacteriophage encode and express endolysins to hydrolyze a critical covalent bond in the peptidoglycan (i.e. cell wall) of bacteria, resulting in host cell lysis and liberation of progeny virions. Notably, these enzymes possess the ability to extrinsically induce lysis to susceptible bacteria in the absence of phage and furthermore have been validated both in vitro and in vivo for their therapeutic potential3-5. The subject of our directed evolution study involves the PlyC endolysin, which is composed of PlyCA and PlyCB subunits6. When purified and added extrinsically, the PlyC holoenzyme lyses group A streptococci (GAS) as well as other streptococcal groups in a matter of seconds and furthermore has been validated in vivo against GAS7. Significantly, monitoring residual enzyme kinetics after elevated temperature incubation provides distinct evidence that PlyC loses lytic activity abruptly at 45 °C, suggesting a short therapeutic shelf life, which may limit additional development of this enzyme. Further studies reveal the lack of thermal stability is only observed for the PlyCA subunit, whereas the PlyCB subunit is stable up to ~90 °C (unpublished observation). In addition to PlyC, there are several examples in literature that describe the thermolabile nature of endolysins. For example, the Staphylococcus aureus endolysin LysK and Streptococcus pneumoniae endolysins Cpl-1 and Pal lose activity spontaneously at 42 °C, 43.5 °C and 50.2 °C, respectively8-10. According to the Arrhenius equation, which relates the rate of a chemical reaction to the temperature present in the particular system, an increase in thermostability will correlate with an increase in shelf life expectancy11. Toward this end, directed evolution has been shown to be a useful tool for altering the thermal activity of various molecules in nature, but never has this particular technology been exploited successfully for the study of bacteriolytic enzymes. Likewise, successful accounts of progressing the structural stability of this particular class of antimicrobials altogether are nonexistent. In this video, we employ a novel methodology that uses an error-prone DNA polymerase followed by an optimized screening process using a 96 well microtiter plate format to identify mutations to the PlyCA subunit of the PlyC streptococcal endolysin that correlate to an increase in enzyme kinetic stability (Figure 1). Results after just one round of random mutagenesis suggest the methodology is generating PlyC variants that retain more than twice the residual activity when compared to wild-type (WT) PlyC after elevated temperature treatment. Directed evolution is defined as a method to harness natural selection in order to engineer proteins to acquire particular properties that are not associated with the protein in nature. Literature has provided numerous examples regarding the implementation of directed evolution to successfully alter molecular specificity and catalysis 1 . The primary advantage of utilizing directed evolution instead of more rational-based approaches for molecular engineering relates to the volume and diversity of variants that can be screened 2 . One possible application of directed evolution involves improving structural stability of bacteriolytic enzymes, such as endolysins. Bacteriophage encode and express endolysins to hydrolyze a critical covalent bond in the peptidoglycan ( i.e. cell wall) of bacteria, resulting in host cell lysis and liberation of progeny virions. Notably, these enzymes possess the ability to extrinsically induce lysis to susceptible bacteria in the absence of phage and furthermore have been validated both in vitro and in vivo for their therapeutic potential 3-5 . The subject of our directed evolution study involves the PlyC endolysin, which is composed of PlyCA and PlyCB subunits 6 . When purified and added extrinsically, the PlyC holoenzyme lyses group A streptococci (GAS) as well as other streptococcal groups in a matter of seconds and furthermore has been validated in vivo against GAS 7 . Significantly, monitoring residual enzyme kinetics after elevated temperature incubation provides distinct evidence that PlyC loses lytic activity abruptly at 45 °C, suggesting a short therapeutic shelf life, which may limit additional development of this enzyme. Further studies reveal the lack of thermal stability is only observed for the PlyCA subunit, whereas the PlyCB subunit is stable up to ~90 °C (unpublished observation). In addition to PlyC, there are several examples in literature that describe the thermolabile nature of endolysins. For example, the Staphylococcus aureus endolysin LysK and Streptococcus pneumoniae endolysins Cpl-1 and Pal lose activity spontaneously at 42 °C, 43.5 °C and 50.2 °C, respectively 8-10 . According to the Arrhenius equation, which relates the rate of a chemical reaction to the temperature present in the particular system, an increase in thermostability will correlate with an increase in shelf life expectancy 11 . Toward this end, directed evolution has been shown to be a useful tool for altering the thermal activity of various molecules in nature, but never has this particular technology been exploited successfully for the study of bacteriolytic enzymes. Likewise, successful accounts of progressing the structural stability of this particular class of antimicrobials altogether are nonexistent. In this video, we employ a novel methodology that uses an error-prone DNA polymerase followed by an optimized screening process using a 96 well microtiter plate format to identify mutations to the PlyCA subunit of the PlyC streptococcal endolysin that correlate to an increase in enzyme kinetic stability ( Figure 1 ). Results after just one round of random mutagenesis suggest the methodology is generating PlyC variants that retain more than twice the residual activity when compared to wild-type (WT) PlyC after elevated temperature treatment. Directed evolution is defined as a method to harness natural selection in order to engineer proteins to acquire particular properties that are not associated with the protein in nature. Literature has provided numerous examples regarding the implementation of directed evolution to successfully alter molecular specificity and catalysis(1). The primary advantage of utilizing directed evolution instead of more rational-based approaches for molecular engineering relates to the volume and diversity of variants that can be screened(2). One possible application of directed evolution involves improving structural stability of bacteriolytic enzymes, such as endolysins. Bacteriophage encode and express endolysins to hydrolyze a critical covalent bond in the peptidoglycan (i.e. cell wall) of bacteria, resulting in host cell lysis and liberation of progeny virions. Notably, these enzymes possess the ability to extrinsically induce lysis to susceptible bacteria in the absence of phage and furthermore have been validated both in vitro and in vivo for their therapeutic potential(3-5). The subject of our directed evolution study involves the PlyC endolysin, which is composed of PlyCA and PlyCB subunits(6). When purified and added extrinsically, the PlyC holoenzyme lyses group A streptococci (GAS) as well as other streptococcal groups in a matter of seconds and furthermore has been validated in vivo against GAS(7). Significantly, monitoring residual enzyme kinetics after elevated temperature incubation provides distinct evidence that PlyC loses lytic activity abruptly at 45 °C, suggesting a short therapeutic shelf life, which may limit additional development of this enzyme. Further studies reveal the lack of thermal stability is only observed for the PlyCA subunit, whereas the PlyCB subunit is stable up to ~90 °C (unpublished observation). In addition to PlyC, there are several examples in literature that describe the thermolabile nature of endolysins. For example, the Staphylococcus aureus endolysin LysK and Streptococcus pneumoniae endolysins Cpl-1 and Pal lose activity spontaneously at 42 °C, 43.5 °C and 50.2 °C, respectively(8-10). According to the Arrhenius equation, which relates the rate of a chemical reaction to the temperature present in the particular system, an increase in thermostability will correlate with an increase in shelf life expectancy(11). Toward this end, directed evolution has been shown to be a useful tool for altering the thermal activity of various molecules in nature, but never has this particular technology been exploited successfully for the study of bacteriolytic enzymes. Likewise, successful accounts of progressing the structural stability of this particular class of antimicrobials altogether are nonexistent. In this video, we employ a novel methodology that uses an error-prone DNA polymerase followed by an optimized screening process using a 96 well microtiter plate format to identify mutations to the PlyCA subunit of the PlyC streptococcal endolysin that correlate to an increase in enzyme kinetic stability (Figure 1). Results after just one round of random mutagenesis suggest the methodology is generating PlyC variants that retain more than twice the residual activity when compared to wild-type (WT) PlyC after elevated temperature treatment.Directed evolution is defined as a method to harness natural selection in order to engineer proteins to acquire particular properties that are not associated with the protein in nature. Literature has provided numerous examples regarding the implementation of directed evolution to successfully alter molecular specificity and catalysis(1). The primary advantage of utilizing directed evolution instead of more rational-based approaches for molecular engineering relates to the volume and diversity of variants that can be screened(2). One possible application of directed evolution involves improving structural stability of bacteriolytic enzymes, such as endolysins. Bacteriophage encode and express endolysins to hydrolyze a critical covalent bond in the peptidoglycan (i.e. cell wall) of bacteria, resulting in host cell lysis and liberation of progeny virions. Notably, these enzymes possess the ability to extrinsically induce lysis to susceptible bacteria in the absence of phage and furthermore have been validated both in vitro and in vivo for their therapeutic potential(3-5). The subject of our directed evolution study involves the PlyC endolysin, which is composed of PlyCA and PlyCB subunits(6). When purified and added extrinsically, the PlyC holoenzyme lyses group A streptococci (GAS) as well as other streptococcal groups in a matter of seconds and furthermore has been validated in vivo against GAS(7). Significantly, monitoring residual enzyme kinetics after elevated temperature incubation provides distinct evidence that PlyC loses lytic activity abruptly at 45 °C, suggesting a short therapeutic shelf life, which may limit additional development of this enzyme. Further studies reveal the lack of thermal stability is only observed for the PlyCA subunit, whereas the PlyCB subunit is stable up to ~90 °C (unpublished observation). In addition to PlyC, there are several examples in literature that describe the thermolabile nature of endolysins. For example, the Staphylococcus aureus endolysin LysK and Streptococcus pneumoniae endolysins Cpl-1 and Pal lose activity spontaneously at 42 °C, 43.5 °C and 50.2 °C, respectively(8-10). According to the Arrhenius equation, which relates the rate of a chemical reaction to the temperature present in the particular system, an increase in thermostability will correlate with an increase in shelf life expectancy(11). Toward this end, directed evolution has been shown to be a useful tool for altering the thermal activity of various molecules in nature, but never has this particular technology been exploited successfully for the study of bacteriolytic enzymes. Likewise, successful accounts of progressing the structural stability of this particular class of antimicrobials altogether are nonexistent. In this video, we employ a novel methodology that uses an error-prone DNA polymerase followed by an optimized screening process using a 96 well microtiter plate format to identify mutations to the PlyCA subunit of the PlyC streptococcal endolysin that correlate to an increase in enzyme kinetic stability (Figure 1). Results after just one round of random mutagenesis suggest the methodology is generating PlyC variants that retain more than twice the residual activity when compared to wild-type (WT) PlyC after elevated temperature treatment. Directed evolution is defined as a method to harness natural selection in order to engineer proteins to acquire particular properties that are not associated with the protein in nature. Literature has provided numerous examples regarding the implementation of directed evolution to successfully alter molecular specificity and catalysis(1). The primary advantage of utilizing directed evolution instead of more rational-based approaches for molecular engineering relates to the volume and diversity of variants that can be screened(2). One possible application of directed evolution involves improving structural stability of bacteriolytic enzymes, such as endolysins. Bacteriophage encode and express endolysins to hydrolyze a critical covalent bond in the peptidoglycan (i.e. cell wall) of bacteria, resulting in host cell lysis and liberation of progeny virions. Notably, these enzymes possess the ability to extrinsically induce lysis to susceptible bacteria in the absence of phage and furthermore have been validated both in vitro and in vivo for their therapeutic potential(3-5). The subject of our directed evolution study involves the PlyC endolysin, which is composed of PlyCA and PlyCB subunits(6). When purified and added extrinsically, the PlyC holoenzyme lyses group A streptococci (GAS) as well as other streptococcal groups in a matter of seconds and furthermore has been validated in vivo against GAS(7). Significantly, monitoring residual enzyme kinetics after elevated temperature incubation provides distinct evidence that PlyC loses lytic activity abruptly at 45 °C, suggesting a short therapeutic shelf life, which may limit additional development of this enzyme. Further studies reveal the lack of thermal stability is only observed for the PlyCA subunit, whereas the PlyCB subunit is stable up to ~90 °C (unpublished observation). In addition to PlyC, there are several examples in literature that describe the thermolabile nature of endolysins. For example, the Staphylococcus aureus endolysin LysK and Streptococcus pneumoniae endolysins Cpl-1 and Pal lose activity spontaneously at 42 °C, 43.5 °C and 50.2 °C, respectively(8-10). According to the Arrhenius equation, which relates the rate of a chemical reaction to the temperature present in the particular system, an increase in thermostability will correlate with an increase in shelf life expectancy(11). Toward this end, directed evolution has been shown to be a useful tool for altering the thermal activity of various molecules in nature, but never has this particular technology been exploited successfully for the study of bacteriolytic enzymes. Likewise, successful accounts of progressing the structural stability of this particular class of antimicrobials altogether are nonexistent. In this video, we employ a novel methodology that uses an error-prone DNA polymerase followed by an optimized screening process using a 96 well microtiter plate format to identify mutations to the PlyCA subunit of the PlyC streptococcal endolysin that correlate to an increase in enzyme kinetic stability (Figure 1). Results after just one round of random mutagenesis suggest the methodology is generating PlyC variants that retain more than twice the residual activity when compared to wild-type (WT) PlyC after elevated temperature treatment. |
Author | Heselpoth, Ryan D. Nelson, Daniel C. |
AuthorAffiliation | 1 Institute for Bioscience and Biotechnology Research, University of Maryland |
AuthorAffiliation_xml | – name: 1 Institute for Bioscience and Biotechnology Research, University of Maryland |
Author_xml | – sequence: 1 givenname: Ryan D. surname: Heselpoth fullname: Heselpoth, Ryan D. – sequence: 2 givenname: Daniel C. surname: Nelson fullname: Nelson, Daniel C. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23169108$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU1LHTEUhoNY_P4LJQsXUrhtTjIzSTaC2msVbLuoxe5CbuZcb2Qm0SRXuf56Z1CLdtPVOXAeHl7es03WQwxIyC6wz0Jq-FJxaNbIFuiKTZiSf9bf7JtkO-cbxhrOarVBNrmARgNTW-TqiP7AB_rLJcTgwzX9jmURWzqPiZYF0q8-oSvY0ul97JbFx0DjnF4uMPUxFzvrkB7bAUg-dqviHZ2Gx1WPeZd8mNsu497L3CG_T6eXJ2eTi5_fzk-OLiauAigTLaXkXIJyUkDLKiVBoIYGOGtUwyqoa2ykdq62qAWCUrxtW8YECpy1mokdcvjsvV3OemwdhpJsZ26T721amWi9eX8JfmGu470R9dhFNQgOXgQp3i0xF9P77LDrbMC4zIbzWnBQmun_ogCq0aLS9Yh-fBvrb57X4gfg0zPgUsw54dw4X-zY75DSdwaYGb9qxq8O8P4_8KvvHfYEDHieQA |
CitedBy_id | crossref_primary_10_3389_fmicb_2016_00825 crossref_primary_10_7717_peerj_879 crossref_primary_10_1128_AEM_00446_16 crossref_primary_10_1016_j_biotechadv_2017_12_009 crossref_primary_10_1186_s12985_020_01403_0 crossref_primary_10_1128_AEM_00054_19 crossref_primary_10_1016_j_copbio_2015_10_005 crossref_primary_10_3390_v7062758 crossref_primary_10_3390_biom10010064 crossref_primary_10_1080_10408398_2019_1584874 |
ContentType | Journal Article |
Copyright | Copyright © 2012, Journal of Visualized Experiments 2012 |
Copyright_xml | – notice: Copyright © 2012, Journal of Visualized Experiments 2012 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 5PM |
DOI | 10.3791/4216 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | AGRICOLA MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology Engineering |
EISSN | 1940-087X |
ExternalDocumentID | PMC3520584 23169108 10_3791_4216 |
Genre | Video-Audio Media Research Support, U.S. Gov't, Non-P.H.S Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIGMS NIH HHS grantid: T32 GM080201 |
GroupedDBID | --- 223 29L 53G 5GY AAHBH AAHTB AAYXX ABPEJ ACGFO ADBBV AKRSQ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION CS3 DIK E3Z GX1 HYE OK1 RPM SJN CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 5PM |
ID | FETCH-LOGICAL-c411t-977722718c731d048713e91612068604155e679cc5ae93e1882ddd003e3ebd903 |
ISSN | 1940-087X |
IngestDate | Thu Aug 21 14:18:01 EDT 2025 Fri Jul 11 13:11:24 EDT 2025 Fri Jul 11 04:01:40 EDT 2025 Thu Jan 02 22:16:32 EST 2025 Tue Jul 01 05:24:55 EDT 2025 Thu Apr 24 23:07:21 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 69 |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c411t-977722718c731d048713e91612068604155e679cc5ae93e1882ddd003e3ebd903 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 Correspondence to: Daniel C. Nelson at nelsond@umd.edu |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC3520584 |
PMID | 23169108 |
PQID | 1186934959 |
PQPubID | 23479 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3520584 proquest_miscellaneous_2253218909 proquest_miscellaneous_1186934959 pubmed_primary_23169108 crossref_citationtrail_10_3791_4216 crossref_primary_10_3791_4216 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20121107 |
PublicationDateYYYYMMDD | 2012-11-07 |
PublicationDate_xml | – month: 11 year: 2012 text: 20121107 day: 7 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Journal of visualized experiments |
PublicationTitleAlternate | J Vis Exp |
PublicationYear | 2012 |
Publisher | MyJove Corporation |
Publisher_xml | – name: MyJove Corporation |
References | 18824123 - Curr Opin Microbiol. 2008 Oct;11(5):393-400 20144680 - Biochimie. 2010 May;92(5):507-13 10712737 - Biotechnol Bioeng. 2000 Apr 20;68(2):211-7 11577980 - Cell Mol Life Sci. 2001 Aug;58(9):1216-33 15972815 - J Biol Chem. 2005 Oct 7;280(40):34324-31 20003468 - Microb Cell Fact. 2009;8:66 14660638 - J Biol Chem. 2004 Mar 19;279(12):11495-502 16325201 - J Mol Biol. 2006 Jan 27;355(4):858-71 8454587 - J Biol Chem. 1993 Mar 25;268(9):6125-30 11259652 - Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):4107-12 11166567 - Trends Biochem Sci. 2001 Feb;26(2):100-6 17160051 - Nat Biotechnol. 2006 Dec;24(12):1508-11 18411226 - Protein Eng Des Sel. 2008 May;21(5):319-27 19474348 - Nucleic Acids Res. 2009 Jul;37(13):4472-81 18573077 - Annu Rev Biophys. 2008;37:153-73 2004447 - Clin Chem. 1991 Mar;37(3):398-402 16212665 - Microb Cell Fact. 2005 Oct 07;4:29 19454214 - Anal Biochem. 2009 May 1;388(1):71-80 16818874 - Proc Natl Acad Sci U S A. 2006 Jul 11;103(28):10765-70 15979390 - Curr Opin Microbiol. 2005 Aug;8(4):480-7 15857780 - Biomol Eng. 2005 Jun;22(1-3):21-30 15247237 - J Biol Chem. 2004 Oct 15;279(42):43697-707 |
References_xml | – reference: 11166567 - Trends Biochem Sci. 2001 Feb;26(2):100-6 – reference: 17160051 - Nat Biotechnol. 2006 Dec;24(12):1508-11 – reference: 16818874 - Proc Natl Acad Sci U S A. 2006 Jul 11;103(28):10765-70 – reference: 11259652 - Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):4107-12 – reference: 15857780 - Biomol Eng. 2005 Jun;22(1-3):21-30 – reference: 15972815 - J Biol Chem. 2005 Oct 7;280(40):34324-31 – reference: 19474348 - Nucleic Acids Res. 2009 Jul;37(13):4472-81 – reference: 10712737 - Biotechnol Bioeng. 2000 Apr 20;68(2):211-7 – reference: 2004447 - Clin Chem. 1991 Mar;37(3):398-402 – reference: 15247237 - J Biol Chem. 2004 Oct 15;279(42):43697-707 – reference: 11577980 - Cell Mol Life Sci. 2001 Aug;58(9):1216-33 – reference: 20003468 - Microb Cell Fact. 2009;8:66 – reference: 15979390 - Curr Opin Microbiol. 2005 Aug;8(4):480-7 – reference: 18573077 - Annu Rev Biophys. 2008;37:153-73 – reference: 18411226 - Protein Eng Des Sel. 2008 May;21(5):319-27 – reference: 16325201 - J Mol Biol. 2006 Jan 27;355(4):858-71 – reference: 16212665 - Microb Cell Fact. 2005 Oct 07;4:29 – reference: 20144680 - Biochimie. 2010 May;92(5):507-13 – reference: 8454587 - J Biol Chem. 1993 Mar 25;268(9):6125-30 – reference: 14660638 - J Biol Chem. 2004 Mar 19;279(12):11495-502 – reference: 18824123 - Curr Opin Microbiol. 2008 Oct;11(5):393-400 – reference: 19454214 - Anal Biochem. 2009 May 1;388(1):71-80 |
SSID | ssj0062058 |
Score | 2.0627043 |
Snippet | Directed evolution is defined as a method to harness natural selection in order to engineer proteins to acquire particular properties that are not associated... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
SubjectTerms | anti-infective agents bacteria bacteriophages cell walls chemical bonding chemical reactions directed evolution DNA-directed DNA polymerase endolysin Endopeptidases - chemistry Endopeptidases - genetics Endopeptidases - metabolism engineering enzyme kinetics Enzyme Stability equations Escherichia coli - enzymology Escherichia coli - genetics Heating Immunology monitoring mutagenesis Mutagenesis, Site-Directed natural selection peptidoglycans progeny Recombinant Proteins - biosynthesis Recombinant Proteins - chemistry Recombinant Proteins - genetics Recombinant Proteins - metabolism screening shelf life Staphylococcus aureus Streptococcus - enzymology Streptococcus - genetics Streptococcus pneumoniae temperature therapeutics thermal stability Transformation, Bacterial - genetics virion |
Title | A New Screening Method for the Directed Evolution of Thermostable Bacteriolytic Enzymes |
URI | https://www.ncbi.nlm.nih.gov/pubmed/23169108 https://www.proquest.com/docview/1186934959 https://www.proquest.com/docview/2253218909 https://pubmed.ncbi.nlm.nih.gov/PMC3520584 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwGLVgCDQhIe4rMGQEbyhdbKex_VhGUYU0HmATe6vixBOTSjKt3aT213McJ27aFXF5iSLHTiwf-_P5nO9CyDuVqjOlYxWZTPMoYVZHWmY6So1JeCKUKmr_iqMv6fgk-Xw6OG0zZDfeJXPTz5db_Ur-B1WUAVfnJfsPyIaXogD3wBdXIIzrX2E8rM0Tv-XOdsap_Ed1OuhgOejFGRjl6LrphqOGmBiXPyuQQucz9cEHa66mCxe4dVQuF61HyE3Cen0-cx6YS7xwlRcgUPKxndnpReWPab4uIDY-9lcnzW1MSO_R_v6w3z1tYLx2u5MdAamdOaiq09tj_9hS5ueLz7-yKZ-F1E4-J5xtCX-9sS0FY0GoKa7dxLW6Te5w6ANxeyzjt9yUx3Ui1tCRe-R-87UD12qdc9xQJDbtYTsE4_ghedAMNB16mB-RW7Z8TO76XKGLJ-T7kAJsGsCmHmwKsCnApi3YNIBNqzPaBZuugU0bsJ-Sk0-j48Nx1GTFiPKEsTmWEgaAg1LkUrACAlgyYUHyGXfePi7iwsCmUuf5ILNaWAYVqigKCG8rrCl0LJ6RnbIq7R6hA56zTJqC29QkcYZlWxhjVZFLrXhieY-8bcdtkjch413mkumki0mP7IdaFz5EysbzN-2QTyC73A-prLTV1Qzap0q1gIquf18H-40ADdUx6jz3MIWvQDdJQXdVj8g1AEMFFzt9_Ul5_qOOoQ69A3MmefGHvr8ku6tV8IrszC-v7D5Y6Ny8rmfgL_5qilk |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+New+Screening+Method+for+the+Directed+Evolution+of+Thermostable+Bacteriolytic+Enzymes&rft.jtitle=Journal+of+visualized+experiments&rft.au=Heselpoth%2C+Ryan+D.&rft.au=Nelson%2C+Daniel+C.&rft.date=2012-11-07&rft.issn=1940-087X&rft.eissn=1940-087X&rft.issue=69&rft_id=info:doi/10.3791%2F4216&rft.externalDBID=n%2Fa&rft.externalDocID=10_3791_4216 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1940-087X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1940-087X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1940-087X&client=summon |